IP Library Granted Patent US 10,106,780
Granted Patent B2
US 10,106,780 · App. 14/128,547 · Granted Oct 23, 2018

Adhesive signature-based methods for the isolation of stem cells and cells derived therefrom

Inventors: Ankur Singh (Smyrna, GA); Shalu Suri (Smyrna, GA); Todd Christopher McDevitt (Atlanta, GA); Hang Lu (Atlanta, GA); Andres Jose Garcia (Atlanta, GA)
Assignee: Georgia Tech Research Corporation
C12N5/0696C12N5/0623C12Q1/686G01N33/56966C12N2506/45C12N2509/10C12N2527/00C12N2539/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,106,780
App. No.
14/128,547
Granted
Oct 23, 2018
Kind
B2
Abstract

The present invention provides for methods of isolating a stem cell or cell derived therefrom from a mixture of cells, for example, a mixture of adherent cells in culture. Cell isolation is achieved by the application of selective detachment forces.

Claims (11)

1. A method of isolating a human induced pluripotent stem cell (hiPSC) and/or a human embryonic stem cell (hESC) from fibroblasts adhered to a substrate:

a) growing a mixture of cells comprising fibroblasts and an hiPSC and/or an hESC on a substrate in culture, such that the cells in the mixture of cells are adhered to the substrate; and

b) subjecting the mixture of adhered cells comp rising fibroblasts and an hiPSC and/or an hESC to a detachment force that provides a wall shear stress in the range from about 70 to about 160 dynes/cm 2 , wherein the detachment force selectively detaches the hiPSC and/or hESC from the mixture of adhered cells, thereby isolating the hiPSC and/or hESC from the mixture of cells adhered to the substrate.

2. The method of claim 1 , wherein the detachment force that is sufficient to selectively detach the hiPSC and/or hESC provides a wall shear stress in the range from about 85 to about 125 dynes/cm 2 .

3. The method of claim 1 , wherein the method further comprises culturing the isolated hiPSC and/or hESC.

4. The method of claim 1 , wherein the method further comprises evaluating the isolated hiPSC and/or hESC by flow cytometry, biochemical analysis and/or gene expression analysis.

5. The method of claim 1 , wherein the method does not comprise attaching a detectable label and/or affinity reagent to the mixture of animal cells.

6. The method of claim 1 , wherein the detachment force is applied by hydrodynamic force, centrifugal force and/or magnetic force.

7. The method of claim 1 , wherein the method is carried out in a microfluidic device.

8. The method of claim 1 , wherein the mixture of cultured cells is subjected to the detachment force for 1 to 60 minutes.

9. The method of claim 1 , wherein the mixture of cultured cells is subjected to the detachment force for 2 to 20 minutes.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 23, 2014
From: LU, HANG
To: GEORGIA TECH RESEARCH CORPORATION
Reel/Frame 032956/0469 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 23, 2014
From: SINGH, ANKUR; SURI, SHALU
To: GEORGIA TECH RESEARCH CORPORATION
Reel/Frame 032956/0512 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 23, 2014
From: GARCIA, ANDRES JOSE
To: GEORGIA TECH RESEARCH CORPORATION
Reel/Frame 032956/0561 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 23, 2014
From: MCDEVITT, TODD CHRISTOPHER
To: GEORGIA TECH RESEARCH CORPORATION
Reel/Frame 032956/0612 →
CONFIRMATORY LICENSE Recorded Jan 22, 2014
From: GEORGIA TECH RESEARCH CORPORATION
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 032111/0552 →
Continuity (2)
Provisional Application 61499323 · Jun 21, 2011
Related Publication 20140357506A1 · Dec 4, 2014